account_id none on file
legal_name Tenax Therapeutics, Inc.
ticker TENX
cik 34956
domain tenaxthera.com
linkedin_company_url https://www.linkedin.com/company/tenax-therapeutics
entry_point_account_id none on file
name Tenax Therapeutics Inc.
exchange Nasdaq
sector Health Care
hq Chapel Hill, NC, United States
sector index/company/sector/health-care/
calls 0 filings 3 executives 8 family 0
why_nownone on file
callsnone on file
filings
Salary and benefits costs increased by $0.5 million and $1.0 million for the three and six months ended June 30, 2026, respectively, as compared to the same period in the prior year primarily due to the hiring of additional development personnel resulting in higher salary and benefit costs.
filing / Jul 31, 2026 / receipt
Salary and benefits costs increased by $0.5 million for the three months ended March 31, 2026 as compared to the same period in the prior year primarily due to higher salaries and additional performance-based compensation expense as a result of an increase in the number of employees.
filing / May 12, 2026 / receipt
Staab, II as Chief Financial Officer of the Company effective May 11, 2026 (the “Start Date”). The Company’s current Interim Chief Financial Officer and Principal Financial Officer and Principal Accounting Officer, Thomas A.
filing / May 12, 2026 / receipt
executives
| Christopher T. Giordano | Chief Executive Officer | - | receipt |
| John Kelley | director | - | receipt |
| Lawrence R. Hoffman | Interim Chief Financial Officer | - | receipt |
| Michael B. Jebsen | Interim Chief Executive Officer | - | receipt |
| Richard M. Kiral | President and Chief Operating Officer | - | receipt |
| Steven J. Boyd | director | - | receipt |
| Stuart Rich | Chief Medical Officer | - | receipt |
| Thomas A. McGauley | Interim Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-11 | earnings call | scheduled | ir |
changes
| 2024-12-04 | Interim Chief Financial Officer, appointed | sec_8k |
| 2024-01-12 | Interim Chief Financial Officer, appointed | sec_8k |
| 2021-07-08 | Chief Executive Officer, appointed | sec_8k |
| 2021-07-08 | Chief Executive Officer, retiring | sec_8k |
| 2021-01-19 | Chief Medical Officer, appointed | sec_8k |
| 2020-07-20 | director, appointed | sec_8k |
| 2018-06-05 | Chief Executive Officer, appointed | sec_8k |
| 2017-04-07 | Chief Executive Officer, departed | sec_8k |
| 2017-04-07 | Interim Chief Executive Officer, appointed | sec_8k |
| 2013-12-23 | director, appointed | sec_8k |
| 2013-11-19 | Chief Executive Officer, appointed | sec_8k |
| 2010-03-04 | Director, departed | sec_8k |
mcp_package_hint
slug tenax-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$